Grifols SA : Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience – 4-traders (press release)

July 12, 2012 Posted By: Leave a comment
Legal firm Osborne Clarke acted as Grifols' advisors and Rousaud ... As a Grifols investment vehicle it currently owns shares of Nanotherapix (51% equity share), Araclon Biotech (51% equity share), and now of VCN Biosciences (40% equity share).
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>